Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Creative Medical Technology Holdings (CELZ) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to -$1.2 million.

  • Creative Medical Technology Holdings' Net Income towards Common Stockholders fell 1882.44% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 1209.91%. This contributed to the annual value of -$5.5 million for FY2024, which is 391.38% down from last year.
  • Latest data reveals that Creative Medical Technology Holdings reported Net Income towards Common Stockholders of -$1.2 million as of Q3 2025, which was down 1882.44% from -$1.2 million recorded in Q2 2025.
  • Creative Medical Technology Holdings' Net Income towards Common Stockholders' 5-year high stood at $27.9 million during Q1 2021, with a 5-year trough of -$6.2 million in Q4 2022.
  • For the 5-year period, Creative Medical Technology Holdings' Net Income towards Common Stockholders averaged around -$306298.2, with its median value being -$1.5 million (2023).
  • Over the last 5 years, Creative Medical Technology Holdings' Net Income towards Common Stockholders had its largest YoY gain of 63545.12% in 2021, and its largest YoY loss of 56356.47% in 2021.
  • Creative Medical Technology Holdings' Net Income towards Common Stockholders (Quarter) stood at -$3.9 million in 2021, then plummeted by 60.39% to -$6.2 million in 2022, then soared by 72.99% to -$1.7 million in 2023, then dropped by 10.46% to -$1.9 million in 2024, then skyrocketed by 33.34% to -$1.2 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$1.2 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$1.6 million for Q1 2025.